tiprankstipranks
Leerinks downgrades Ideaya Biosciences pending clarity on key programs
PremiumThe FlyLeerinks downgrades Ideaya Biosciences pending clarity on key programs
21d ago
Ideaya Biosciences downgraded to Market Perform from Outperform at Leerink
Premium
The Fly
Ideaya Biosciences downgraded to Market Perform from Outperform at Leerink
21d ago
IDEAYA Biosciences: Q3 2024 Financial and Clinical Progress
Premium
Company Announcements
IDEAYA Biosciences: Q3 2024 Financial and Clinical Progress
22d ago
Ideaya Biosciences initiated with a Buy at UBS
PremiumThe FlyIdeaya Biosciences initiated with a Buy at UBS
1M ago
Ideaya Biosciences initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
Ideaya Biosciences initiated with an Overweight at Cantor Fitzgerald
1M ago
Ideaya Biosciences management to meet with Oppenheimer
Premium
The Fly
Ideaya Biosciences management to meet with Oppenheimer
2M ago
Ideaya Biosciences price target lowered to $66 from $68 at Stifel
PremiumThe FlyIdeaya Biosciences price target lowered to $66 from $68 at Stifel
2M ago
Ideaya Type C meeting outcome ‘best case,’ says Oppenheimer
Premium
The Fly
Ideaya Type C meeting outcome ‘best case,’ says Oppenheimer
2M ago
Ideaya Biosciences announces interim darovasertib trial data
Premium
The Fly
Ideaya Biosciences announces interim darovasertib trial data
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100